Skip to main content
. Author manuscript; available in PMC: 2016 Nov 10.
Published in final edited form as: Age Ageing. 2008 Oct 1;37(6):621–627. doi: 10.1093/ageing/afn203

Table 3.

Predictive validity analyses for trials included in meta-analysis, fixed- and random-effects meta-analyses and test of homogeneity (patients in geriatric rehabilitation settings)

A B C D SENS SPEC PPV NPV
Coker [34] 73 171 38 150 65.8 (56.5, 73.9) 46.7 (41.3, 52.2) 29.9 (24.5, 35.9) 79.8 (73.5, 84.9)
Haines [37] 20 47 6 49 76.9 (58.0, 89.0) 51.0 (41.2, 60.8) 29.9 (20.2, 41.7) 89.1 (78.2, 94.9)
Hill [37] 3 21 4 16 42.9 (15.8, 75.0) 43.2 (28.7, 59.1) 12.5 (4.3, 31.0) 80.0 (58.4, 91.9)
Milisen [39] 55 248 27 357 67.1 (56.3, 76.3) 59.0 (55.0, 62.9) 18.2 (14.2, 22.9) 93.0 (90.0, 95.1)
Fixed-effects estimate [95% CI] 67.2 [61.1, 73.3] 54.1 [51.1, 57.1] 22.5 [19.3, 25.7] 90.5 [88.3, 92.7]
Random-effects estimate [95% CI] 67.2 [60.8, 73.6] 51.2 [43.0, 59.3] 23.1 [14.9, 31.2] 86.5 [78.4, 94.6]
Q (df)a, P-value 3.18 (3), 0.3646 15.17 (3), 0.0017 14.18 (3), 0.0027 18.45 (3), 0.0004
Fallers Non-fallers
STRATIFY cut-off ≥2 Ab Bb
STRATIFY cut-off <2 Cb Db
a

Q = test of homogeneity chi-squared statistic; df = degrees of freedom;

b

SENS = A/(A + C), SPEC = D/(B + D), PPV = A/(A + B), NPV = D/(C + D).